Back
Axsome Therapeutics Vs. ePlus Industry Stock Comparison
Buy
82
AXSM
Axsome Therapeutics
Last Price:
98.03
Seasonality Move:
52.64%
Sell
27
PLUS
ePlus
Last Price:
80.47
Seasonality Move:
20.86%
Buy
82
Axsome Therapeutics (AXSM)
is a Buy
Is Axsome Therapeutics a Buy, Sell or Hold?
- The current Axsome Therapeutics [AXSM] share price is $97.83. The Score for AXSM is 82, which is 64% above its historic median score of 50, and infers lower risk than normal.
- AXSM is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
27
ePlus (PLUS)
is a Sell
Is ePlus a Buy, Sell or Hold?
- The current ePlus [PLUS] share price is $80.03. The Score for PLUS is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- PLUS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
AXSM Stock Price Chart
What is Axsome Therapeutics's stock price today?
-
The Axsome Therapeutics share price today is $97.83
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AXSM is experiencing selling pressure, which indicates risk of future bearish movement.
PLUS Stock Price Chart
AXSM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.45 | Buy |
| Relative Strength Index (14 RSI): | 65.11 | Buy |
| Chaikin Money Flow: | -1194644 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (86.36 - 93.52) | Buy |
| Bollinger Bands (100): | (83.2 - 92.02) | Buy |
PLUS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.37 | Sell |
| Relative Strength Index (14 RSI): | 28.12 | Sell |
| Chaikin Money Flow: | -371573 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (91.15 - 100.85) | Sell |
| Bollinger Bands (100): | (81.19 - 98.29) | Sell |
AXSM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 92.05 | Buy |
| 20-day SMA: | 91.12 | Buy |
| 50-day SMA: | 90.63 | Buy |
| 200-day SMA: | 82.53 | Buy |
| 8-day EMA: | 93.43 | Buy |
| 20-day EMA: | 91.34 | Buy |
| 50-day EMA: | 89.78 | Buy |
| 200-day EMA: | 83.38 | Buy |
PLUS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 93.25 | Sell |
| 20-day SMA: | 94.97 | Sell |
| 50-day SMA: | 95.27 | Sell |
| 200-day SMA: | 83.59 | Sell |
| 8-day EMA: | 92.26 | Sell |
| 20-day EMA: | 94.28 | Sell |
| 50-day EMA: | 94.05 | Sell |
| 200-day EMA: | 84.44 | Sell |
Axsome Therapeutics Earnings Growth & AXSM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $1.19 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.73 per share, and an increase next year of $3.57 per share.
ePlus Earnings Growth & PLUS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.53 per share, and a decrease next year of $0.07 per share.
Axsome Therapeutics Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
ePlus Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||